🇺🇸 trivalent split influenza vaccine in United States

trivalent split influenza vaccine (trivalent split influenza vaccine) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

trivalent split influenza vaccine in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is trivalent split influenza vaccine approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for trivalent split influenza vaccine in United States?

Novartis is the originator. The local marketing authorisation holder may differ — check the official source linked above.